HENDERSON, NV -- (Marketwired) -- 05/16/16 -- United Health Products Inc. (OTCQB: UEEC) announced that Optimal Government Resources has signed their distribution agreement and placed an opening stocking order. In conjunction with this agreement, UHP HemoStyp® products are now listed under the DAPA contract # SP0200-09-H-0037. This begins an exciting new chapter for United Health Products and allows all US military, US government agencies and VA systems to order directly or via their Prime Vendor agreements.
Optimal GS is a participant in the Department of Defense (DOD) and Department of Veterans Affairs Medical/Surgical Prime Vendor Programs (MSPV), and the DOD and VA Pharmaceutical Prime Vendor Program (PPV). Optimal has commercial agreements with the National and Regional Prime Vendors to ensure highly efficient national distribution of its products to its Federal Customer Base. This customer base includes the DOD, all branches of the military, all federal government offices and programs. Optimal GS specializes in distribution of medical products through this network, utilizing the MSPV bridge contracts. The VA has created a major benefit to our Nation's Veterans by continuing to provide efficient and unparalleled medical supply support to VA medical centers nationwide. The program is mandatory for all VA medical centers. The MSPV program includes McKesson and Cardinal distribution.
About United Health Products Inc.
United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its products, and expanding its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com
Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.
United Health Products Inc.